Pelage expects to initiate late-stage studies in 2026, designed to further evaluate the safety and efficacy of PP405 in patients with androgenetic alopecia. About Pelage Pharmaceuticals. Pelage ...
Following completion of the offering, PelagicCredit Plc has a post-money equity capitalisation of approximately USD 75 million ... We congratulate Pelagic Credit and all parties involved on this important milestone.”.
Cypriot shipowner and shipping fund manager PelagicPartners has announced the successful listing and the first day of trading of its new investment platform, Pelagic Credit, on the Oslo Stock Exchange.
PelagicPartners’ shipping credit platform, Pelagic Credit, has added an offshore support vessel to its growing portfolio ... based on current SOFR swap rates, Pelagic Credit said in a filing.
PelagicCredit has raised NOK558m ($58m) in a private placement, clearing the way for its planned listing in Oslo... Earlier in February, Pelagic Credit had targeted gross proceeds of between $107m and $132m before trimming the deal size to around $75m.